Applications Published 11 October 2000

Published: 26-Apr-2001

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • A delivery of arginine to caue beneficial effects
    Strategic Science & Technology 1041880*

  • Transvascular delivery of a compsn to an extravascular tissue of a mammal
    The Trustees of the University of Pennsylvania 1041882*

  • Tablet compsn
    Procter & Gamble 1041965*

  • Pharmaceutical compsns
    AstraZeneca 1041966*

  • Microparticles and their therapeutic or diagnostic use
    Quadrant Healthcare 1041967*

  • Osmotic delivery system with membrane plug retention mechanism
    Alza Corp 1041968*

  • Novel pharmaceutical compsns of uridine triphosphate
    Inspire Pharmaceuticals 1041969*

  • Compsns of microspheres for wound healing
    Polyheal 1041970*

  • A method of making a pharmaceutical formulation
    Leiras OY 1041971*

  • Tablet for instant and prolonged release of one or more active agents
    Merck Patent 1041972*

  • Microcapsules, process for preparing micrcapsules containing a biologically active compound and a liquid solution
    Industria E Comercio de Cosmeticos Natura 1041973*

  • Beneficial agent delivery system with membrane plug
    Alza Corp 1041974*

  • Rate controlling membranes for controlled drug delivery system
    Alza Corp 1041975*

  • Polyamide oligomers
    Inex Pharmaceuticals 1041976*

  • Use of PPAR-gamma activators in dermatology
    Galderama Research & Development 1041977*

  • Methods of inactivating bacteria including bacterial spores
    The Regents of the University of Michigan Technology Management 1041978*

  • Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof
    DCV Inc, doing business as Bio-Technical Resources 1041979*

  • Acyl guanidine sodium/proton exchange inhibitors and method
    Bristol-Myers Squibb 1041980*

  • Inhibition of P38 kinase activity using substituted heterocyclic ureas
    Bayer 1041982*

  • Application of enzyme prodrugs as anti-infective agents
    Newbiotics 1041983*

  • Pharmaceutical compsn for oral administration
    Sanofi-Synthelabo 1041984*

  • Combination of benzocycloheptapyridine compounds and antineoplastic agents for treating proliferative diseases
    Schering 1041985*

  • Pharmaceutically active compounds and methods of use
    Cambridge Neurosciences 1041986*

  • Opioid agonist/antagonist combinations
    Euro-Celtique 1041987*

  • A method of preventing abuse of opioid dosage forms
    Euro-Celtique 1041988*

  • Novel cycloalkenyl substituted compounds
    SmithKline Beecham 1041989*

  • Compsn for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
    Schering 1041990*

  • Method for inhibiting cyclooxygenase-2 and tumour necrosis factor alpha
    New York University 1041991*

  • Hyperhydrated citicoline, process and use
    Interneuron Pharmaceuticals 1041992*

  • Ophthalmic compsns and process of using
    Smith, Stewart Gregory 1041993*

  • Use of parasitic biological agents for prevention and control of autoimmune diseases
    University of Iowa Research Foundation 1041994*

  • Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
    Enzon 1041995*

  • Keratinocyte growth factor-2 formulations
    Human Genome Sciences 1041996*

  • Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
    Universite Paul Sabatier 1041997*

  • Compsn and method for dermal and transdermal administration of a cytokine
    Pharmaderm Laboratories 1041998*

  • Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumour vascular endothelium
    Nuvas 1041999*

  • Delivery of multiple genes to cells using pluro adeno-associated viral vectors
    Cell Genesys 1042000*

  • Use of microparticles combined with submicron oil-in-water emulsions
    Chiron 1041001*

  • Pharmaceutical formulations and processes for their preparation
    DuPont Pharmaceuticals 1042002*

  • Delivery of long-lasting therapeutic aents by forming covalent attachments in vivo
    Conjuchem 1042003*

  • Method for tissue perfusion
    Direct Therapeutics 1042004*

  • Method of creating a biostatic agent using interpenetrating network polymers
    Biosafe 1042005*

  • A method for disinfecting liquids and gases and devices for use thereof
    Tribelski, Zamir 1042006*

  • Aminobiguanidines and the use thereof to disinfect contact lenses and preserve pharmaceutical compsns
    Alcon Laboratories 1042007*

  • Antimicrobial compsn delivery system with an integrated filter
    Steris Corp 1042009*

  • Pharmaceutical compsn and methods for use
    RJ Reynolds Tobacco Co 1042274*

  • Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
    NPS Phamaceuticals 1042275*

  • Thiourea and benzamide compounds, compsns and methods of treating or preventing inflammation diseases and atherosc lerosis
    Warner-Lambert 1042275*

  • Naphthalene derivatives
    Fujisawa Pharmaceuticals 1042277*

  • 1,3-disubstituted useas as ACAT inhibitors, and method of preparing thereof
    Slovakofarma 1042278*

  • Substituted beta-alanines
    Aventis Pharma 1042279*

  • Prodrugs of aspartyl protease inhibitors
    Vertex Pharmaceuticals 1042280*

  • Process for the preparation of fluorinated sulphinates
    Minnesota Mining and Manufacturing 1042281*

  • Methods and preparing aromatic thiols and derivatives, reagents, intermediate products and method for obtaining them
    Rhodia Chemie 1042282*

  • A process for the purification of caprolactam obtained from the depolymerisation of polyamide-containing carpet
    AlliedSignal 1042284*

  • Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
    Wei, Edward 1042286*

  • Indole derivatives as inhibitors of factor XA
    Aventis Pharma Deutschland 1042287*

  • Tripeptidyl peptidase inhibitors
    Institut National de la Sante et de la Recherche Medicale 1042288*

  • Aromatic sulphone hydroxamic acid metalloprotease inhibitor
    GD Searle 1042290*

  • Aryl-substituted pyridylalkene, and alkine carboxamides useful as cyctostatic and immunosuppresive agents
    Klinge Pharma 1042291*

  • Method for producing isoureas
    Takeda Chemical Industries 1042292*

  • Substituted pyridine and pyridazine compounds and their pharmaeutical use
    Amgen 1042293*

  • Hetrocyclic cytotoxic agents
    Rutgers, the State University of New Jersey 1042294*

  • 4-hydroxyquinoline-3-carboxamides and hydrazines as antiviral agents
    Pharmacia & Upjohn 1042295*

  • Substituted isoquinoline derivatives and their use as anticonvulsants
    SmithKline Beecham 1042296*

  • Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
    Amgen 1042297*

  • Polycyclic alpha-amino-epsilon-caprolactams and related compounds
    Elan Pharmaceuticals 1042298*

  • Nitrogen containing heteroaromatics with ortho-substituted P1's as factor XA inhibitors
    DuPont Pharmaceuticals 1042299*

  • Phthalazine derivatives phosphodiesterase 4 inhibitors
    Zambon Group 1042300*

  • Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
    Aventis Pharma Deutschland 1042301*

  • Triazine compounds for treatment of CS disorders
    Glaxo Group 1042304*

  • Inhibition of P38 kinase using symmetrical and unsymmetrical diphenyl ureas
    Bayer 1042305*

  • Thiazole-, isothiazole- ad thiadiazole-derivatives having microbicidal and plant immunising activities
    Novartis 1042306*

  • Aminothiazole inhibitors of cyclin dependent kinases
    Bristol-Myers Squibb 1042307*

  • Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity
    Allergan Sales 1042313*

  • Method of preparing enantiomerically-enriched terahydrobenzothiepine oxides
    GD Searle 1042314*

  • Cyclic imide-substituted pyridylalkane, alkene and alkine carboxamides useful as cytostatic and immunosuppresive agents
    Klinge Pharma 1042315*

  • Indole derivatives useful AO for the treatment of osteoporosis
    SmithKline Beecham Laboratoires Pharmaceutiques 1042316*

  • New pharmaceutically active compounds
    AstraZeneca 1042317*

  • Process for the preparation of paroxetine hydrochloride
    SmithKline Beecham 1042318*

  • Dihydrobenzofurans
    Byk Gulden Lomberg Chemische Fabrik 1042319*

  • New compounds which are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists
    AstraZeneca 1042320*
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now